Deniz Tschammler is a leading lawyer at the intersection of life sciences, healthcare, and technology.

With deep industry experience and a sophisticated understanding of the global health ecosystems, Deniz is a trusted advisor for corporates and investors in the pharmaceutical, medical technology, and health tech space. Deniz guides clients on their most significant:

  • Transactions and strategic collaborations
  • Regulatory and healthcare compliance matters
  • Health tech and health data projects
  • Disputes and investigations

Deniz is a member of the executive committee of the German-American Lawyers’ Association.

Deniz’s experience includes advising:

  • DHL Group on the acquisition of CRYOPDP, a leading specialty courier focused on clinical trials, biopharma, as well as cell and gene therapies
  • Oakley Capital on acquiring Flemming Dental, Excent & Artinorway Group*
  • Elos Medtech on its merger with Klingel Medical Group*
  • Myonex on acquiring Hubertus Pharmacy’s clinical trial business*
  • AUCTUS Capital Partners AG on selling PharmaLex Group*
  • Lifespin on concluding a research cooperation with Biobank Graz and the Clinical Department of Oncology at Medical University of Graz*
  • STADA Arzneimittel AG on a licensing collaboration with Calliditas Therapeutics AB for approving and marketing a novel specialty pharmaceutical candidate*
  • Merck KGaA on negotiating a cooperation agreement with neuroloop GmbH, an early-stage startup company of B. Braun Group*

*Matter handled prior to joining Latham

Bar Qualification

  • Rechtsanwalt (Germany)

Education

  • Executive MBA, University of St. Gallen, 2021
  • LLM, King's College London, 2013
  • Second State Exam, Regional Court, Wiesbaden, 2012
  • Dr. jur., University of Marburg, 2011
  • First State Exam, Goethe University of Frankfurt, 2008